Cirdan
Private Company
Total funding raised: $10M
Overview
Cirdan is an established, revenue-generating private company delivering sophisticated laboratory information systems (ULTRA LIS) and digital pathology solutions to healthcare and research labs globally. With over 100 LIS installations and partnerships with 80 national laboratories, it has a proven track record in modernizing pathology workflows. The company recently secured a significant £12.9 million investment to fuel further innovation and global expansion, positioning it to capitalize on the growing demand for lab digitization and AI-enhanced diagnostics.
Technology Platform
ULTRA Laboratory Information System (LIS) with modern database architecture (Oracle), supporting virtualization and disaster recovery. Platform includes digital pathology imaging solutions and an educational digital pathology platform (Cirdan Tutor). Integrated with real-time data analysis and AI tools for workflow optimization.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Cirdan competes in the laboratory informatics market against large enterprise health IT vendors (e.g., Epic, Cerner), broad LIMS providers (e.g., LabVantage, Thermo Fisher), and specialized digital pathology software companies. Its differentiation lies in its deep focus on pathology workflows, proven scalability for national lab networks, and integrated approach combining LIS, imaging, and education.